Moderna Inc (MRNA)

Interest coverage

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019
Earnings before interest and tax (EBIT) (ttm) US$ in thousands -4,239,000 -2,665,000 513,000 4,827,000 9,420,000 13,250,000 15,642,000 16,257,000 13,296,000 7,611,000 3,818,000 634,000 -763,000 -618,556 -514,320 -536,029 -546,670 -569,145
Interest expense (ttm) US$ in thousands -32,000 -28,000 -30,000 -38,000 29,000 25,000 21,000 21,000 18,000 15,506 14,349 11,226 9,891 8,041 6,842 6,599 6,557 6,472
Interest coverage 324.83 530.00 744.86 774.14 738.67 490.84 266.08 56.48 -77.14 -76.93 -75.17 -81.23 -83.37 -87.94

December 31, 2023 calculation

Interest coverage = EBIT (ttm) ÷ Interest expense (ttm)
= $-4,239,000K ÷ $-32,000K
= —

As the interest coverage ratio for Moderna Inc is not provided in the table for any of the quarters listed, it is not possible to determine the company's ability to meet its interest obligations using this metric. The interest coverage ratio is a key financial indicator that assesses a company's ability to pay interest expenses on its outstanding debt. It is calculated by dividing a company's earnings before interest and taxes (EBIT) by its interest expenses. A higher ratio indicates that a company is more capable of servicing its interest payments. Without the specific data for Moderna Inc's interest coverage ratio, further analysis of the company's debt servicing capabilities based on this metric is not feasible.


Peer comparison

Dec 31, 2023


See also:

Moderna Inc Interest Coverage (Quarterly Data)